Guidance

Diphtheria disease and azithromycin: PGD template

Patient Group Direction (PGD) for the supply of azithromycin for the prevention of diphtheria in high risk settings or during outbreaks.

• From: UK Health Security Agency
• Published: 11 November 2022
• Last updated: 22 November 2022 — See all updates

Applies to England

Documents

Prophylaxis azithromycin for diphtheria disease: PGD template

Ref: UKHSA gateway number GOV-13702

MS Word Document, 156 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This PGD supports the supply or administration of azithromycin to adults and children aged 1 year and older with potential exposure to diphtheria in high risk settings or during outbreaks.

PGD version 02.00 is valid from 21 November 2022 to 20 November 2024.

The PGD template requires further authorisation by a clinical governance or patient safety lead who has designated responsibility for signing PGDs. It is not legal or valid without this local, formal authorisation.

The authorising commissioning body and providers are responsible for the adoption and governance of use of this PGD. Provider organisations and health professionals should check they are using the current version and only work to a legally authorised PGD from their commissioning body.

For further information see the supplementary guidance for cases and outbreaks in asylum seeker accommodation settings and the diphtheria document collection for other resources.

Published 11 November 2022
Last updated 22 November 2022 + show all updates

1. 22 November 2022

   Added version 02.00.

2. 11 November 2022

   First published.